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ABSTRACT
The characterization of transcription factor com-
plexes and their binding sites in the genome by affin-
ity purification has yielded tremendous new insights
into how genes are regulated. The affinity purification
requires either the use of antibodies raised against
the factor of interest itself or by high-affinity bind-
ing of a C- or N-terminally added tag sequence to
the factor. Unfortunately, fusing extra amino acids to
the termini of a factor can interfere with its biolog-
ical function or the tag may be inaccessible inside
the protein. Here, we describe an effective solution
to that problem by integrating the ‘tag’ close to the
nuclear localization sequence domain of the factor.
We demonstrate the effectiveness of this approach
with the transcription factors Fli-1 and Irf2bp2, which
cannot be tagged at their extremities without loss of
function. This resulted in the identification of novel
proteins partners and a new hypothesis on the con-
tribution of Fli-1 to hematopoiesis.
INTRODUCTION
Transcription factors (TFs) regulate gene expression
through their recruitment to gene regulatory sequences
(1). They often function as protein complexes cooperating
with other TFs or cofactors to regulate many biological
processes, such as cellular proliferation and differentiation.
For example, protein complexes containing the Ldb1 TF
have been shown to control erythroid differentiation by
regulating the expression of key erythroid-specific genes (2).
Much of our current knowledge of the molecular mech-
anisms TF use to regulate gene expression comes from the
identification of their genomic binding sites by chromatin
immunoprecipitation (ChIP) experiments and the identifi-
cation of their protein partners by pull-down assays usu-
ally followed by mass spectrometry (MS) analysis to deter-
mine the identity of the co-precipitated factors. These ap-
proaches rely on the efficient and specific purification of
the proteins and DNA bound by the factor of interest us-
ing antibodies. The availability of high-affinity antibodies
against particular TFs is, therefore, critical for experimen-
tal success. These experiments are usually single-step pu-
rifications and/or are performed on low number of cells.
The antibodies should therefore be efficient and very spe-
cific to obtain a high signal-to-noise ratio to allow the iden-
tification of true DNA/protein or protein/protein interac-
tions. However, suitable antibodies are often not available
at all or perform suboptimally. A popular alternative to an-
tibodies is therefore the generation of a fusion between a
small epitope ‘tag’ sequence and the protein of interest be-
cause purification strategies for these are readily available.
These short peptide sequences, which are either recognized
by high-affinity antibodies or by streptavidin (biotag), have
been widely used alone or in combination to characterize
TF complexes and genome-wide binding sites (3–5). The
peptide tag is fused to either the N-terminal or to the C-
terminal end of the protein, however, the addition of extra
amino acids to one or both termini can disrupt protein func-
tion and/or its stability, as exemplified by the Myef2 pro-
tein (6). Because most proteins are modular in structure, an
alternative strategy to circumvent problems with terminal
tagging would be to integrate the tag sequence next to a
domain within the protein (7,8). Several constraints need
to be respected for this approach. Most importantly, the
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tag should not be integrated in a functional domain of the
protein, which is often not well defined. Moreover, the tag
should be positioned in a region of the protein that is ex-
pected to be highly exposed to the cellular milieu in order to
promote recognition by antibodies or by the BirA enzyme.
Again, such information is usually not available. We there-
fore thought of using a domain that is almost ubiquitously
present and accessible in TFs, namely, the nuclear localiza-
tion signal (NLS).
TFs contain a NLS recognized by the importin
/importin  heterodimers that transport the protein
from the cytoplasm through the nuclear pore into the
nucleus (9). This domain will be exposed in all cells
where the TF is active, although it can be regulated by
post-translational modifications (e.g. phosphorylation) or
by NLS masking. A well-studied example of the latter is
the control of NF-B nuclear import that is regulated by
its interaction with IB, which masks the NF-B NLS to
prevent its nuclear import (10). Together with structural
studies of the FUS NLS (11), the data indicate that the
NLS forms an exposed site on the protein that can be
recognized by the importin complex.
Here, we address the possibility to make use of the ex-
posed NLS for tagging purposes by integrating a tag se-
quence close to the NLS as an alternative for the classi-
cal C-/N-terminal approach and used two ‘difficult’ pro-
teins, Fli-1 and Irf2bp2, to test this strategy. A 3×Flag-
biotin peptide was integrated close to the NLS of these TFs,
whose C-/N-terminal tagging disrupt their function (data
not shown). Their expression in an erythroid progenitor
cell line (which also expresses these protein endogenously)
showed that their function is unaffected. We then used the
NLS-tagged Fli-1 protein to identify its protein partners by
MS analysis in erythroid cells for the first time and found
novel protein partners belonging to the key erythroid Ldb1
TF complex.
MATERIALS AND METHODS
Plasmid constructs
Expression vectors for 3×Flag-Bio(NLS)-Fli-1 and
3×Flag-Bio(NLS)-Irf2bp2 were obtained by stepwise
insertion of Fli-1 and Irf2bp2 cDNA parts into a modified
pBud plasmid containing the 3×Flag sequence. First,
the N-terminal coding part up to the NLS sequence was
inserted followed by the insertion of the C-terminal coding
part containing the bio-tag. The different coding parts
have been obtained by polymerase chain reaction (PCR)
amplification from a MEL cells cDNA library using the
primers listed in Supplementary Table S2. Constructs
were verified by Sanger sequencing before transfection in
MEL/BirA cells (12). Clones were selected using neomycin
at 1 mg/ml. Only clones expressing the same level as the
endogenous protein were used for analysis.
Cell culture
MEL cell lines were maintained in Dulbecco’s modified Ea-
gle’s medium supplemented with 10% fetal calf serum and
penicillin/streptomycin. Cells were induced by culturing
them in presence of 2% of di-methyl sulphoxide (DMSO)
for 4 days.
Nuclear extracts
Cells were washed twice with 1× phosphate buffered saline
(PBS) and resuspended in 8 ml of cold buffer A (10 mM
HEPES-KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5
mM DTT, 1× Complete ethylenediaminetetraacetic acid
(EDTA)-free protease inhibitor mix (Roche)). After 10 min
of incubation in ice, lysates were vortexed and spun down 10
s at 13 200 revolutions per minute (rpm) at 4◦C. Pellets were
resuspended in 1 volume of buffer C (20 mMHEPES-KOH
pH 7.9, 25% glycerol, 420 mM KCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5 mM DTT, 1× Complete EDTA-free pro-
tease inhibitor mix (Roche)) and incubated 20 min in ice.
Lysates were vortexed and pelleted 2 min at 13 200 rpm at
4◦C. The supernatant was used for further experiments.
Co-immunoprecipitation
Co-immunoprecipitation experiments were performed
starting from 1 mg (2 mg for MS) of nuclear extracts
prepared as mentioned above and diluted to 150 mM
KCl with Heng0 buffer (20 mM HEPES-KOH pH 7.9,
20% glycerol, 0.25 mM EDTA pH 8.0, 0.05% NP-40, 1×
Complete EDTA-free protease inhibitor mix (Roche)).
Note that 10 l of magnetic beads (Dynabeads M-280,
Life Science) (blocked during 1 h in presence of 0.2 g/l
Chicken Egg Albumin) coated with streptavidin for 1 mg of
proteins are added to the nuclear extracts together with 100
U benzonase (Roche). After 3 h of incubation at room tem-
perature, the beads were washed five times with Heng150
(20 mM HEPES-KOH pH 7.9, 20% glycerol, 0.25 mM
EDTA pH 8.0, 0.2% NP-40, 150 mM KCl, 1× Complete
EDTA-free protease inhibitor mix (Roche)) for 5 min at
room temperature and directly resuspended in 2× Laemmli
buffer (120 mM Tris-HCl, pH 6.8, 4% sodium dodecyl
sulphate (SDS), 20% (w/v) glycerol, 0.01% bromophenol
blue, 400 mM DTT). Finally, the beads were boiled 5
min and discarded. Co-immunoprecipitation experiments
using the anti-Flag antibody (M2, Sigma-Aldrich) were
performed as mentioned above except that the nuclear
extracts were incubated with 10 g of antibody and 10 l
of magnetic beads coated with protein G for 4 h at room
temperature.
Western blot
Nuclear extracts or immunoprecipitated proteins were
boiled in Laemmli buffer and loaded onto NuPAGE pre-
cast 4–12% gradient Bis-Tris acrylamide gels (Invitrogen).
Proteins were transferred to nitrocellulose membranes and
probed for the protein of interest using the antibodies men-
tioned below. Fluorescently labeled secondary antibodies
(Licor) were used for visualization and membranes were
scanned on an Odyssey Imaging System.
The following primary antibodies were used : Rabbit
anti-Fli-1 (Abcam, ab-15289), Rat anti-Gata-1 (Santa Cruz
Biotechnology, N6), Rabbit anti-Irf2bp2 (Absea), Rabbit
anti-Klf1 (5-V) (kindly provided by Dr. Sjaak Philipsen),
Mouse anti-Vcp (Abcam).
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Figure 1. Expression of NLS-tagged Fli-1 and Irf2bp2 proteins in MEL cells. (a) Schematic depicting Fli-1 protein domain organization and the 3×Flag-
Bio tag integration site. The Fli-1 pointed (PNT) domain is involved in the interaction with other proteins, the ETS domain is the DNA binding domain.
Fli-1 has two NLSs localized between aminoacids 62 and 126 (NLS1) and between aminoacids 277 and 360 (NLS2). The 3×Flag and BirA target sequence
(Bio) were integrated in between amino acids 60 and 61, just before the NLS1. (b) Schematic depicting Irf2bp2 protein domain organization and the
3×Flag-Bio tag integration site. Irf2bp2 contains one zinc finger (ZF) and one RING domain. The NLS of this factor is localized between amino acids
333 and 422. The 3×Flag and Bio sequences were integrated in between amino acids 331 and 332. (c and d) Total proteins were extracted from either
MEL/BirA, MEL/BioFli-1 (c) or MEL/BioIrf2bp2 (d) cells and subjected to Western blot analysis. Membranes were probed using an antibody against
the endogenous proteins (top) or using streptavidin (bottom).
Quantitative reverse transcriptase-PCR (RT-PCR)
Total RNA was extracted from the different cell lines us-
ing TRI Reagent (Sigma). First-strand cDNA was synthe-
sized using the SuperScript II First Strand Synthesis System
(Invitrogen) and oligo-dT primers (Invitrogen). Real-time
PCR was performed using Platinium Taq Polymerase and
SYBRgreen (Invitrogen) cDNAon aBio-RadCFX96 PCR
System. Ribonuclease/angiogenin 1 (Rnh1) was amplified
in parallel for normalization purposes. Primer sequences are
listed in Supplementary Table S3.
ChIP followed by real-time PCR
Note that 1 × 107 cells were cross-linked 50 min at
room temperature using DSG (Di(N-succinimidyl) glu-
tarate) 50 mM (Proteochem), washed twice with 1× PBS
followed by an additional cross-linking step of 10 min us-
ing 1% formaldehyde (Merck). The cross-linking reaction
was stopped by adding 0.125 MGlycine. Cells were washed
twice with 1× cold PBS and resuspended in sonication
buffer (Tris-HCl 10 mM pH8.0, EDTA 1 mM, EGTA 0.5
mM). After 10 min of incubation in ice, chromatin was son-
icated for 33 cycles (15 s ON, 30 s OFF Amp 9) using the
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Figure 2. Proper nuclear localization of theNLS-tagged proteins inMEL cells. (a–i) Immunofluorescence experiments inMEL/BirA (a, b, c),MEL/BioFli-
1 (d, e, f) and MEL/BioIrf2bp2 (g, h, i) cells using either DAPI (a, d, g) or streptavidin conjugated with Alexa fluor 488 (b, e, h). The figure c, f and i show
the merged picture. (j and k) Total (lanes 1 and 2) and nuclear (lanes 3 and 4) proteins were extracted from MEL/BirA (lanes 1 and 3), MEL/BioFli-1
(j, lanes 2 and 4) and MEL/BioIrf2bp2 (k, lanes 2 and 4) and subjected to Western blot analysis. Membranes were probed using an antibody against the
endogenous protein (top panel) or against Vcp (bottom panel, loading control).
Soniprep 150 (Beun de Ronde) to get fragments of 500–800
bp. The sonicated chromatin from 106 cells was then diluted
20 times in ChIP dilution buffer (0.01% SDS, 1.1% Triton
X-100, 1.2 mMEDTA, 16.7 mMTris-HCl pH 8.0, 167 mM
NaCl) and incubated overnight in presence of 10 l of mag-
netic beads (Dynabeads M-280, Life Science) (blocked for
1 h with 1.5% fish skin gelatin and 200 ng sonicated salmon
sperm DNA). The beads were then washed once with Low
Salt Buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20
mM Tris-HCl pH 8.0, 150 mMNaCl), once with High Salt
Buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris-HCl pH 8.0, 500 mM NaCl), once with LiCl Buffer
(0.25 M LiCl, 1% NP-40, 1% deoxycholixacid sodium salt,
1 mM EDTA, 10 mM Tris-HCl pH 8.0) and twice with TE
buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA). The beads
were then decrosslinked in presence of Elution Buffer (1%
SDS, 0.1 M NaHCO3) during 4 h at 65◦C and treated for 1
h with 20 g proteinase K. Finally, DNA was purified.
ChIP using the anti-Fli-1 (Santa Cruz Biotechnology, sc-
356) was performed using the same protocol as described
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Figure 3. NLS-tagged Fli-1 and Irf2bp2 interact with endogenous interacting proteins. (a) Streptavidin-IP on nuclear extracts from MEL-BirA (lanes 1
and 3) or MEL/BioFli-1 cells (lanes 2 and 4) followed by Western blot analysis of Vcp (top panel, loading control), the endogenous and the NLS-tagged
Fli-1 proteins (middle top panel), Gata-1 (middle bottom panel) and Klf1 (bottom panel). The picture is representative of two independent experiments.
(b) Flag-IP of nuclear extracts fromMEL/BirA (lanes 1 and 3) or MEL/BioFli-1 cells (lanes 2 and 4) followed by Western blot analysis of Vcp (top panel,
loading control), the endogenous and the NLS-tagged Fli-1 proteins (middle top panel), Gata-1 (middle bottom panel) and Klf1 (bottom panel). The
picture is representative of two independent experiments. (c) Streptavidin-IP of nuclear extracts fromMEL/BirA (lines 1 and 3) or MEL/BioIrf2bp2 cells
(line 2 and 4) followed by Western blot analysis of the endogenous and the NLS-tagged Irf2bp2 proteins (top panel), Irf2 (middle panel) and Vcp (bottom
panel, loading control). The picture is representative of two independent experiments. (d) Flag-IP of nuclear extracts from MEL/BirA (lines 1 and 3) or
MEL/BioIrf2bp2 cells (lines 2 and 4) followed by Western blot analysis of the endogenous and the NLS-tagged Irf2bp2 proteins (top panel), Irf2 (middle
panel) and Vcp (bottom panel). The picture is representative of two independent experiments.
above except for the following differences. The diluted son-
icated chromatin was incubated for 30 min with agarose
beads coated with protein A and G (Santa Cruz Biotech-
nology). After spinning 1 min at 1000 rpm at 4◦C, the chro-
matin of 106 cells was incubated overnight at 4◦C with ei-
ther 10 g of anti-Fli-1 antibody or the same amount of
Rabbit immunoglobulin G (IgG; Santa Cruz Biotechnol-
ogy). Agarose beads coated with protein A andGwere then
added and the samples were incubated for 1 h at 4◦C on a
rotating wheel.
Immunofluorescence
Cells were sediment for 15 min on a poly-L-lysine coated
glass slide for 15 min at room temperature and fixed for
15 min with 2% PBS/paraformaldehyde at room temper-
ature. Cells were then quickly washed three times with
PBS/0.1% Triton-X100 and twice with the same buffer for
10 min. After an extra quick wash with PBS/0.5% bovine
serum albumin (BSA)/0.15% Glycine, cells were incubated
for 2 h at room temperature with streptavidin conjugated
with Alexa Fluor 488 diluted 250 times with PBS/0.5%
BSA/0.15% Glycine. Cells were quickly washed three times
with PBS/0.1% Triton-X100, washed for 10 min with same
buffer and finally quickly washedwith 1×PBS.A total of 10
l prolong GOLD were added to the cells and a coverslip
was mounted. After 24 h overnight at room temperature,
slides were visualized in the confocal microscope Lyca SP5.
Mass spectrometry
The beads containing bound TF complexes (see Co-
immunoprecipitation section) were washed twice with 50
mM NH4HCO3 and incubated overnight at 37◦C with
shaking with 0.1 g of trypsin/50 l beads. The digests are
analyzed by nanoflow liquid chromatography-tandem MS
on a LTQ-Orbitrap (Thermo) mass spectrometer coupled
to an 1100 series LC pump and autosampler (Agilent) op-
erating in positive mode and equipped with a nanospray
source. Peptide mixtures were trapped on a ReproSil C18
reversed phase column (Dr.MaischGmbH; column dimen-
sions 1.5 cm 100 m, packed in-house) with a flow rate
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Figure 4. NLS-tagged Fli-1 and Irf2bp2 are recruited to the endogenous protein target regions. (a) ChIP experiments with the anti-Fli-1 antibody (black
bars) or the Control IgG (white bars) from MEL cells followed by qPCR using primers amplifying β-amylase (control region), Fli-1 promoter, Nip7
promoter and a region within the Tgfb1 locus. Data represents the average of three independent experiments; error bars denote standard deviation. (b)
Streptavidin-ChIP from MEL/BirA (white bars) and MEL/BioFli-1 (black bars) cells followed by qPCR using primers amplifying β-amylase (control
region), Fli-1 promoter,Nip7 promoter and a region within the Tgfb1 locus. Data represents the average of six independent experiments; error bars denote
standard deviation, *P < 0.05, Student’s t-test between MEL/BirA and MEL/BioFli-1 cells. (c) Genome-wide Irf2bp2 binding sites in MEL cells were
identified by ChIP-Seq experiments. The different Irf2bp2 genomic binding regions can be visualized by the UCSC genome browser. For example, Irf2bp2
binds a region within the tgfb1 locus, the nip7 gene promoter, the fli-1 gene promoter and two known enhancers of c-myb gene (BS1: Myb −36 kb; BS5:
Myb −68 kb). (d) Streptavidin-ChIP from MEL/BirA (white bars) and MEL/BioIrf2bp2 (black bars) cells followed by qPCR using primers amplifying
β-amylase (control region),Myb −36 kb (BS1),Myb −68 kb (BS5), Fli-1 promoter, Nip7 promoter and a region within the Tgfb1 locus. Data represents
the average of the signal for six independent experiments; error bars denote standard deviation, *P < 0.05, Student’s t-test between MEL/BirA and
MEL/BioIrf2bp2.
of 8 l/min. Peptide separation was performed using a Re-
proSil C18 reversed phase column (Dr. Maisch GmbH; col-
umn dimensions 15 cm 50 m, packed in-house) using
a linear gradient from 0% to 80% B (A = 0.1 M formic
acid; B = 80% (v/v) acetonitrile, 0.1 M formic acid) over
70 min with a constant flow rate of 200 nl/min using a
splitter. The column eluent was directly sprayed into the
electron spray ionization (ESI) source of the mass spec-
trometer (13). Mass spectra were acquired in continuum
mode; while fragmentation of the peptides was performed
in data-dependent mode. Peak lists were automatically cre-
ated from raw data files using the Mascot Distiller software
(version 2.1; MatrixScience). The Mascot search algorithm
(version 2.2, MatrixScience) was used for searching against
the NCBInr database (latest NCBInr release; taxonomy:
Mus musculus). The peptide tolerance was typically set to
10 ppm and the fragment ion tolerance to 0.8 Da. A max-
imum number of two missed cleavages by trypsin were al-
lowed and carbamidomethylated cysteine and oxidized me-
thioninewere set as fixed and variablemodifications, respec-
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Figure 5. NLS-tagged Fli-1 inhibits erythroid differentiation ofMEL cells. (a)Total proteins extracted fromMEL/BirA (lanes 1 and 2) andMEL/BioFli-1
(lanes 3 and 4) cells cultured for 4 days in presence (lanes 2 and 4) or in absence (lanes 1 and 3) of 2% DMSO were subjected to western blot analysis.
Membranes were probed using an antibody against the endogenous protein (top panel) or the Vcp protein (bottom panel, loading control). The figure is
representative of three independent experiments. (b) Pellet of MEL/BirA (left tube) and MEL/BioFli-1 (right tube) cells after 4 days of DMSO treatment.
(c) RT-qPCR experiments on MEL/BirA (white bars) and MEL/BioFli-1 (black bars) cells measuring the expression of β-globin (top left panel), alas2
(top right panel) and sfpi1 (bottom panel). Data represents the average of three independent experiments; error bars denote standard deviation. *P< 0.05,
Student’s t-test between MEL/BirA and MEL/BioFli-1 cells. +P < 0.05, Student’s t-test between untreated and DMSO treated cells.
tively. The Mascot score cut-off value for a positive protein
hit was set to 80 (5).
RESULTS
Generation of MEL cells expressing NLS-tagged Fli-1 and
Irf2bp2 proteins
Fli-1 is expressed as a 51 and 48 kDa protein isoform that
belongs to ETS family of TFs. Like all ETS TFs, it contains
an ETS DNA binding domain of around 85 amino acids
involved in the recognition of a GGAA core consensus se-
quence (14). Fli-1 contains two NLSs: the first NLS is lo-
cated between amino acids 62 and 126 while the second is
localized between amino acids 277 and 360 that correspond
to the ETS domain (Figure 1a) (15). We therefore decided
to integrate the popular triple FLAG (3×FLAG) and a bi-
otin tag (biotag) between amino acids 60 and 61 in a region
that does not contain any known domain critical for Fli-1
function (Figure 1a).
Irf2bp2 is a 60 kDa nuclear protein found to function as
a co-repressor of the IRF2 TF (16). The Irf2bp2 NLS has
been mapped between amino acids 333 and 422. Teng et al.
showed that nuclear localization of Irf2bp2 is dependent on
the phosphorylation of the serine 360 residue (17).We there-
fore decided to integrate the 3×FLAGand a biotag between
amino acids 331 and 332, which do not belong to any im-
portant domain of the Irf2bp2 protein (Figure 1b).
Fli-1 and the Irf2bp2 cDNA containing the tag in the
aforementioned positions were cloned in a modified pBud
vector that allows cDNA expression driven by a EF1
housekeeping gene promoter. These constructs were trans-
fected into MEL cells that express the BirA biotin ligase
(MEL/BirA) at level sufficient to biotinylate TFs carrying
a biotag (2,12). Stable clones expressing the NLS-tagged
proteins were selected based on their expression levels. To-
tal protein extracts were analyzed by western blot using ei-
ther an anti-Fli-1 antibody (Figure 1c, top panel), an anti-
Irf2bp2 antibody (Figure 1d, top panel) or directly using
streptavidin (Figure 1c and d, bottom panel).
Several clones expressing 3×Flag-Bio(NLS)-Fli-1
or 3×Flag-Bio(NLS)-Irf2bp2 were obtained (data not
shown). Figure 1c and d show that MEL/BioFli-1 and
MEL/BioIrf2bp2 cells express the NLS-tagged proteins
at similar levels as the endogenous protein. Moreover,
streptavidin western blot revealed the presence of specific
bands at the expected size of 3×Flag-Bio(NLS)-Fli-1
or 3×Flag-Bio(NLS)-Irf2bp2 in these stable cell lines
(Figure 1c and d, bottom panel).
These data show that the NLS-tagged factors can be ex-
pressed at the same level as the endogenous proteins. More-
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over, tag integration near the NLS allows recognition and
biotinylation of the proteins by BirA biotin ligase.
NLS-tagged Fli-1 and Irf2bp2 are properly localized in the
nucleus
The integration of the tag sequences close to theNLS of Fli-
1 or Irf2bp2 proteins may disrupt their nuclear localization.
Hence, we first performed immunofluorescence assays using
streptavidin conjugated with Alexa-Fluor 488 and Dapi in
MEL/BirA, MEL/BioFli-1 and MEL/BioIrf2bp2 cells.
While no signal was observed in the nucleus using Strep-
tavidin in MEL/BirA control cells (Figure 2b and c), Fig-
ure 2e and f show a clear signal, which merged with DAPI
in MEL/BioFli-1 cells indicating that the NLS-tagged Fli-
1 protein is, as expected, localized in the nucleus. Similarly,
the NLS-tagged Irf2bp2 protein is also localized in the nu-
cleus (Figure 2h and i).
To determine if the NLS-tagged proteins have a similar
nuclear localization as the endogenous protein, we com-
pare the ratio between the exogenous and the endogenous
protein in total protein and nuclear protein extracts of
MEL/BioFli-1 and MEL/BioIrf2bp2 cells. Western blot
analyses shown in Figure 2j (compare lanes 2 and 4) and k
(compare lanes 2 and 4) indicate that the ratio between the
NLS-tagged proteins and the endogenous protein is similar
in total protein extracts compared to nuclear extracts show-
ing that the NLS-tagged proteins have a similar nuclear lo-
calization as the endogenous protein.
Altogether, these results indicate that integration of a
3×Flag and a biotag sequence close to the NLS of Fli-1 and
Irf2bp2 proteins does not disrupt their nuclear localization.
NLS-tagged Fli-1 and Irf2bp2 interact with known protein
partners of the endogenous protein
Even though NLS-tagged proteins are properly localized in
the nucleus, integration of a short peptide sequence within
the Fli-1 and Irf2bp2 proteins could possibly affect their
interaction with other proteins. To test this possibility, we
investigated whether 3×Flag-Bio(NLS)-Fli-1 or 3×Flag-
Bio(NLS)-Irf2bp2 are able to interact with known protein
partners of the endogenous proteins.
We first tested whether the NLS-tagged Fli-1 protein
interacts with Gata-1 and Klf1, two known Fli-1 pro-
tein partners identified in MEL cells and megakaryocytes
(18,19). Streptavidin-IPs were performed in MEL/BirA
control cells, which only express the BirA biotin ligase
and in MEL/BioFli-1, which express the NLS-tagged Fli-
1 protein. The absence of the NLS-tagged Fli-1 protein in
the unbound fraction shows that more than 90% of the
NLS-tagged Fli-1 protein is biotinylated (Figure 3a, com-
pare lanes 2 and 4). Besides, while the streptavidin-IP in
MEL/BirA cells does not pull-down Gata-1 or Klf1 (lane
3), the same experiment in MEL/BioFli-1 cells precipitates
Gata-1 (line 4, middle panel) and Klf1 (lane 4, bottom
panel) together with 3×Flag-Bio(NLS)-Fli-1 (line 4, top
panel). The same experiments using the antibody against
the 3×Flag tag inMEL/BirA andMEL/BioFli-1 cells show
that Gata-1 and Klf1 are also specifically precipitated in
MEL/BioFli-1 cells (Figure 3b). These results show that,
like the endogenous Fli-1 protein, NLS-tagged Fli-1 inter-
acts with Gata-1 and Klf1 despite the presence of the inter-
nal tag sequences.
As mentioned before, Irf2bp2 was first discovered as a
protein partner and corepressor of the IRF2 TF (16). To
check if the NLS-tagged Irf2bp2 also interacts with Irf2,
similar experiments as above were performed inMEL/BirA
and MEL/BioIrf2bp2 cells. The results shown in Figure 3c
and d indicate that NLS-tagged Irf2bp2 indeed interacts
with Irf2 in MEL cells.
Taken together, these results show that the integration of
short sequences close to the Fli-1 and Irf2bp2NLS does not
disrupt their interaction with other proteins.
NLS-tagged Fli-1 and Irf2bp2 are recruited to known binding
regions of the endogenous Fli-1 and Irf2bp2 proteins
TFs modulate gene expression through their binding to
gene regulatory regions. We therefore also investigated
whether the integration of a tag close to the NLS does
not disrupt the DNA binding pattern of NLS-tagged Fli-
1 and Irf2bp2 by performing ChIP experiments using
streptavidin-conjugated beads (BioChIP).
Some target regions of Fli-1 have been reported in MEL
cells using the anti-Fli-1 antibody. Fli-1 was shown to be
recruited to its own promoter (20,21), to the nip7 gene pro-
moter, which encodes a protein involved in ribosome bio-
genesis (22). We confirmed the recruitment of Fli-1 to these
specific regions and also to the tgfb1 locus by performing
ChIP experiments using the anti-Fli-1 antibody in MEL
cells. Although the efficiency of theChIP is variable between
the biological triplicates, we observed a higher enrichment
with the anti-Fli-1 antibody compared to theRabbit IgG for
all these three regions (Figure 4a). We then tested whether
3×Flag-Bio(NLS)-Fli-1 could also be recruited to these loci
inMEL/BioFli-1 cells. BioChIP experiments performed on
these cells and MEL/BirA control cells showed a specific
enrichment in these three loci only in MEL/BioFli-1 cells,
with no enrichment observed in the β-amylase control lo-
cus (Figure 4b). Besides, the efficiency of the BioChIP is
more reproducible than the ChIP with the anti-Fli-1 anti-
body. These results indicate that NLS-tagged Fli-1 is also
recruited to the fli-1 and nip7 promoters as well as the tgfb1
locus in MEL cells.
We recently determined the genome-wide Irf2bp2 bind-
ing sites by ChIP-Seq in MEL cells using an antibody
raised against the endogenous protein (Soler, in prepara-
tion). Interestingly, Irf2bp2 is also recruited to the Fli-1 oc-
cupied loci mentioned above and also binds to two known
enhancers of Myb (23) (Figure 4c). Similar to Fli-1, we
performed BioChIP experiments in MEL/BioIrf2bp2 and
MEL/BirA control cells to verify whether the NLS-tagged
Irf2bp2 protein is also recruited to these specific loci. Fig-
ure 4d indeed shows the recruitment of NLS-tagged Irf2bp2
to five known binding regions of the endogenous Irf2bp2
protein.
Altogether, these results show that the presence of a short
tag sequence close to the Fli-1 and Irf2bp2 NLS does not
affect their recruitment to gene regulatory regions.
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NLS-tagged Fli-1 inhibits MEL cells differentiation
Fli-1 overexpression and depletion experiments performed
in mouse and human cells demonstrated that Fli-1 is a re-
pressor of erythroid differentiation (21,22,24). Specifically
inMEL cells, the overexpression of Fli-1 represses erythroid
differentiation of these cells (21). To further validate the
functionality of the NLS-tagged Fli-1 protein, we exam-
ined the potential of 3×Flag-Bio(NLS)-Fli-1 to repress the
DMSO-induced erythroid differentiation of MEL cells.
As observed in Figure 5a, the 4-day DMSO treatment
does not affect the expression of the NLS-tagged Fli-1.
Control cells obtained a red color, a well-known sign of
hemoglobin synthesis and erythroid differentiation (Fig-
ure 5b, left tube). In contrast, MEL/BioFli-1 cells remain
white after the same treatment indicating that a functional
3×Flag-Bio(NLS)-Fli-1 is able to inhibit erythroid differen-
tiation.
To confirm these observations, we measured the induc-
tion of β-globin and Alas2 expression, two established
markers for terminal erythroid differentiation, by RT-
qPCR experiments. In contrast to MEL BirA control cells,
MEL/BioFli-1 cells show either an impaired (Alas2) or
no (β-globin) induction of erythroid gene expression upon
treatment while both cell type show a decrease of Sfpi-1
gene expression, an early effect of DMSO inMEL cells (25)
(Figure 5c).
Altogether, these results demonstrate that NLS-tagged
Fli-1, similar to the endogenous Fli-1 protein, represses the
erythroid differentiation of MEL cells despite the integra-
tion of a short tag close to its NLS.
Fli-1 interacts with several proteins belonging to the Ldb1
complex
The previous experiments described above show that the in-
tegration of a short epitope tag sequence next to the NLS
of Fli-1 and Irf2bp2 does not affect their function. To take
advantage of the epitope tag for protein purification, we
used the MEL/BioFli-1 cells to purify Fli-1 protein part-
ners in MEL cells by performing immunoprecipitation ex-
periments using streptavidin-conjugated beads followed by
MS in both MEL/BirA control cells and MEL/BioFli-1
cells.
The full list of the identified proteins interacting with Fli-
1 is shown in Supplementary Table S1. According to the
MS results, Fli-1 interacts with 99 proteins. Among these
proteins, some have been already identified by other groups
in different cellular model system. For example, we found
among the 99 interacting proteins, the ETS TF ETV6 (also
called TEL) whose interaction with Fli-1 has been identi-
fied in human K562 cells (26). Moreover, we also found Fli-
1 to interact with the Run×1 TF, an interaction found to
be important for megakaryopoiesis (27) (Figure 6a). These
results further validate the functionality of the NLS-tagged
Fli-1 as a valuable tool to study TFs functions.
Strikingly, among the other proteins we found inter-
acting with Fli-1, several members of the Ldb1 TF com-
plex were detected (Figure 6b). Among these proteins, we
found the core complexmembersGata-1 (whose interaction
was confirmed by streptavidin-IP experiments (Figure 3a),
Tal1/Scl, Ldb1 itself, Tcf3/E2A and several Ssbp proteins).
All Ldb1 complex members were found interacting specifi-
cally in 3×Flag-Bio(NLS)-Fli-1 cells (although Gata-1 was
also found in the MEL/BirA purification, the Mascott
score was less than 2-fold lower as compared to 3×Flag-
Bio(NLS)-Fli-1 cells). We next performed new Flag-IP ex-
periments in MEL/BirA and MEL/BioFli-1 cells to con-
firm the interaction between Fli-1 and Ldb1. As shown in
Figure 6c, Ldb1 is pulled-down together with NLS-tagged
Fli-1 while no signal corresponding to the Ldb1 protein
was detected in MEL/BirA control cells validating our MS
data. We also performed co-immunoprecipitation experi-
ments using MEL cells expressing a bio-tagged Ldb1 (12)
to check whether BioLdb1 interacts with Fli-1. As shown
in Figure 6d, Fli-1 is precipitated more with bio-Ldb1 than
inMEL/BirA control cells while similar amount of proteins
were used in both cells.
In summary, these data indicate that the NLS-tagged Fli-
1 protein is a functional protein that can be efficiently pu-
rified, allowing us to identify for the first time the critical
erythroid Ldb1 TF complex as a Fli-1 protein interacting
partner.
DISCUSSION
Here, we describe a focused strategy of epitope tagging by
integrating the sequence close to the NLS (‘NLS-tagging’)
of two very different TFs that could not be effectively
tagged at their N- or C-terminal end (data not shown). We
have shown that the NLS-tagged proteins still interact with
known protein partners, that they are still recruited to reg-
ulatory sequences bound by the endogenous proteins and
that the NLS-tagged Fli-1, like the endogenous protein, is
still able to repress the erythroid differentiation of MEL
cells. Therefore, we proposeNLS-tagging as an effective and
fast alternative strategy to the common N- or C-terminal
tag integration methods for the characterization of protein
complexes formed by TFs and the identification of their
DNA binding regions.
The NLS-tagging strategy allowed us to show that Fli-
1 interacts with several members of the Ldb1 complex.
This complex is mainly known for its positive regulation of
erythropoiesis by being recruited to regulatory sequences
of erythroid-specific genes (2). This TF complex is also
formed in megakaryocytes where it regulates the expres-
sion of megakaryocytic genes and the megakaryocyte dif-
ferentiation (28). These data highlight similar and oppo-
site contributions of Fli-1 and the Ldb1 complex during
megakaryopoiesis and erythropoiesis, respectively, result-
ing in a new hypothesis about the Fli-1 contribution during
hematopoiesis. Altogether, these data show that our NLS-
tagging strategy can greatly facilitate the elucidation of TF
function during developmental processes, exemplified here
by new insights in the contribution of the Fli-1 protein to
hematopoiesis.
Epitope tag exposure is critical to efficient recognition of
the tag by antibodies (or streptavidin in the case of the bio-
tag). We chose close proximity to the NLS sequence as a
suitable strategy here as theNLS sequence is an often highly
exposed domain of the protein. Although we tested this on
only two proteins, we expect this to work with many if not
all TFs. As a consequence, however, the strategy we pro-
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Figure 6. Fli-1 interacts with several members of the Ldb1 complex in MEL cells. (a) Streptavidin-IP fromMEL/BirA (BirA) andMEL/BioFli-1 (BioFli-
1) nuclear extracts followed by MS was used to identify new Fli-1 protein partners in MEL cells. Table shows the number of peptides detected in both
MEL cells and their corresponding Mascott scores for two known Fli-1 interacting proteins : ETV6 (26) and Runx1 (27). (b) Table depicting several Fli-1
interacting proteins detected by MS belonging to the Ldb1 complex. (c) Flag-IP from MEL/BirA (BirA) (lanes 1, 3 and 5) and MEL/BioFli-1 (lanes 2, 4
and 6) nuclear extracts followed by Western blot analysis of Vcp (top panel, loading control), the endogenous and the NLS-tagged Fli-1 proteins (middle
panel) and the Ldb1 protein (bottom panel). The picture is representative of two independent experiments. (d) Streptavidin-IP from MEL/BirA (BirA)
(lanes 1, 3 and 5) andMEL/BioLdb1 (BioLdb1) (lanes 2, 4 and 6) nuclear extracts followed byWestern blot analysis of Vcp (top panel, loading control), the
endogenous and tagged Ldb1 proteins (middle panel) and the Fli-1 protein (bottom panel). The picture is representative of two independent experiments.
pose can only be readily used for TFs or other nuclear pro-
teins with a known NLS, although the NLS can often be
recognized from the amino acid sequence. There are sev-
eral such sequences, the classical sequence PKKKRKV (29)
for which the consensus K-K/R-X-K/R was proposed or
the bipartite-type sequence KR[PAATKKAGQA]KKKK
(30). Other sequences, such as the PY-NLS motif (proline-
tyrosine pairing), have also been identified as a bona fide
NLS binding importin 2 (31). In addition, the NLS of TF
are usually present either in theDNA-binding domain or its
vicinitymaking this region a likely target to integrate the tag
(32). Other sequences involved in protein localization could
also be chosen for internal tagging of nuclear proteins with
an unknownNLS sequence or cytoplasmic proteins. For ex-
ample, the NES (nuclear export signal) has to be recognized
by proteins, such as CRM1, to export proteins from the
nucleus to cytoplasm and as a consequence, this sequence
should be exposed (33).Moreover, proteins have oftenmod-
ular structure. As we could see for Fli-1 and Irf2bp2 (Fig-
ure 1), they are composed of different functional domains
important for their biological functions. Any place where
domains are linked is potentially a tag sequence integra-
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/42/21/e163/2903175 by Erasm
us U
niversity R
otterdam
 user on 23 August 2019
PAGE 11 OF 12 Nucleic Acids Research, 2014, Vol. 42, No. 21 e163
tion site. However, some will not work properly as they may
be inside the protein. Finally, structural knowledge of the
targeted proteins (i.e. from crystallography studies) would
clearly be advantageous when choosing where to integrate
an internal tag sequence.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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